Program Pascasarjana
Program Studi Ilmu Kedokteran Dasar dan Biomedis
Fakultas Kedokteran

UNIVERSITAS GADJAH MADA

Jajah Fachiroh,S.P, M.Si, Ph.D.

 

 

PENDIDIKAN :

  1. S1 : Mikrobiologi Pertanian, Universitas Gadjah Mada (1996)
  2. S2 : Bioteknologi,Universitas Gadjah Mada (1999)
  3. S3 : Imunovirologi,Free University, Amterdam (2009)

 PENELITIAN :

  1. Fachiroh J, Sangrajrang S, Johansson M, Renard H, Gaborieau V, Chabrier A, Chindavijak S, Brennan P, McKay JD.(2012). Tobacco consumption and genetic susceptibility to nasopharyngeal carcinoma (NPC) in Thailand. Cancer Causes Control.
  2. Paramita DK, Fatmawati C, Juwana H, van Schaijk FG, Fachiroh J, Haryana SM, Middeldorp JM.(2012) Humoral immune responses to Epstein-Barr virus encoded tumor associated proteins and their putative extracellular domains in nasopharyngeal carcinoma patients and regional controls.
  3. Hutajulu SH, N Ng, BR Jati, J Fachiroh, C Herdini, B Hariwiyanto, SM Haryana, J Middeldorp.(2012). Seroreactivity against Epstein-Barr virus (EBV) among first-degree relatives of sporadic EBV-associated nasopharyngeal carcinoma in Indonesia.
  4. Hutajulu SH, Hoebe EK, Verkuijlen SA, Fachiroh J, Hariwijanto B, Haryana SM, Stevens SJ, Greijer AE, Middeldorp JM.(2012).Conserved mutation of Epstein-Barr virus-encoded BamHI-A Rightward Frame-1 (BARF1) gene in Indonesian nasopharyngeal carcinoma.
  5. Fachiroh J, Stevens SJ, Haryana SM, Middeldorp JM.(2012) Combination of Epstein-Barr virus scaffold (BdRF1/VCA-p40) and small capsid protein (BFRF3/VCA-p18) into a single molecule for improved serodiagnosis of acute and malignant EBV-driven disease.
  6. Paramita D., J. Fachiroh, S.M. Haryana, J.M. Middeldorp.(2009). Two-Step Epstein-Barr VirusELISA System for Serological Screening and Confirmation of Nasopharyngeal Carcinoma. Accepted in Clinical and Vaccine Immunology.
  7. Paramita, D., J. Fachiroh, SM Haryana, J Middeldorp.(2008). Evaluation of commercial EBV RecombLine assay for diagnosis of nasopharyngeal carcinoma.
  8. Fachiroh, J., P. Prasetyanti, DK Paramita, AT Prasetyawati, DW Anggrahini, SM Haryana, JM Middeldorp. (2008). Dried-Blood Sampling for Epstein-Barr Virus Immunoglobulin G (IgG) and IgA Serology in Nasopharyngeal Carcinoma Screening.
  9. Paramita, D., J. Fachiroh, WT Artama, E van Benthem, SM Haryana, JM Middeldorp.(2007). Native Early Antigen of Epstein–Barr Virus, a Promising Antigen for Diagnosis of Nasopharyngeal Carcinoma.
  10. SJC. Stevens, SAWM. Verkuijlen, B Hariwiyanto, Harijadi, DK Paramita, J Fachiroh, M Adham, IB Tan, SM Haryana and JM Middeldorp.(2006). Noninvasive diagnosis of nasopharyngeal
  11. J. Fachiroh, D. K. Paramita, B. Hariwiyanto, A. Harijadi, H. L. Dahlia, S. R. Indrasari, H. Kusumo, Y. S. Zeng, T. Schouten, S. Mubarika, and J. M. Middeldorp.(2006). Single-assay combination of Epstein-Barr Virus (EBV) EBNA1- and viral capsid antigen-p18-derived synthetic peptides for measuring anti-EBV immunoglobulin G (IgG) and IgA antibody levels in sera from nasopharyngeal carcinoma patients: options for field screening.
  12. Servi J. C. Stevens, Sandra A. W. M. Verkuijlen, Bambang Hariwiyanto, Harijadi, J. Fachiroh, Dewi K. Paramita, I. Bing Tan, Sophia M. Haryana, and Jaap M. Middeldorp.(2005). Diagnostic value of measuring Epstein-Barr virus (EBV) DNA load and carcinoma-specific viral mRNA in relation to anti-EBV immunoglobulin A (IgA) and IgG antibody levels in blood of nasopharyngeal carcinoma patients from Indonesia."
  13. Fachiroh J, T. Schouten, B. Hariwiyanto, DK. Paramita, A Harijadi, S M. Haryana, MH. Ng, and JM. Middeldorp.(2004). Molecular diversity of Epstein-Barr virus IgG and IgA antibody responses in nasopharyngeal carcinoma: a comparison of Indonesian, Chinese, and European subjects.
  14. T.Yowono, J. Fachiroh, J. Soedarsono.(2004) "Expression of Choline Dehydrogenase in Yeast".

 

PUBLIKASI

Publikasi
Tahun
Jurnal
Penulis
Tobacco consumption and genetic susceptibility to nasopharyngeal carcinoma (NPC) in Thailand.
2012
Cancer Causes Control.  Dec;23(12):1995-2002 Fachiroh J, Sangrajrang S, Johansson M, Renard H, Gaborieau V, Chabrier A, Chindavijak S, Brennan P, McKay JD.
Humoral immune responses to Epstein-Barr virus encoded tumor associated proteins and their putative extracellular domains in nasopharyngeal carcinoma patients and regional controls.
 2011 J Med Virol. 2011 Apr;83(4):665-78. Paramita DK, Fatmawati C, Juwana H, van Schaijk FG, Fachiroh J, Haryana SM, Middeldorp JM.
Seroreactivity against Epstein-Barr virus (EBV) among first-degree relatives of sporadic EBV-associated nasopharyngeal carcinoma in Indonesia.
 2012 J Med Virol. 2012 May;84(5):768-76 Hutajulu SH, N Ng, BR Jati, Fachiroh J,  Herdini C, Hariwiyanto B, SM Haryana,  Middeldorp J
Conserved mutation of Epstein-Barr virus-encoded BamHI-A Rightward Frame-1 (BARF1) gene in Indonesian nasopharyngeal carcinoma.
2010
Infect Agent Cancer. 2010 Sep 19;5:16. Hutajulu SH, Hoebe EK, Verkuijlen SA, Fachiroh J, Hariwijanto B, Haryana SM, Stevens SJ, Greijer AE, Middeldorp JM
Combination of Epstein-Barr virus scaffold (BdRF1/VCA-p40) and small capsid protein (BFRF3/VCA-p18) into a single molecule for improved serodiagnosis of acute and malignant EBV-driven disease.
2010
J Virol Methods. 2010 Oct;169(1):79- 86. Epub 2010 Jul 16. Fachiroh J, Stevens SJ, Haryana SM, Middeldorp JM.
Two-Step Epstein-Barr Virus- ELISA System for Serological Screening and Confirmation of Nasopharyngeal Carcinoma.
 2009  Accepted in Clinical and Vaccine Immunology. Paramita DK,  Fachiroh J, Haryana SM, Middeldorp JM.
Evaluation of commercial EBV RecombLine assay for diagnosis of nasopharyngeal carcinoma.
2008
 J Clin Virol. 42:342-53 Paramita D, Fachiroh J, Haryana SM,  Middeldorp J
Dried-Blood Sampling for Epstein-Barr Virus Immunoglobulin G (IgG) and IgA Serology in Nasopharyngeal Carcinoma Screening.
2008
 J Clin Microbiol 46(4): 1374-80. Fachiroh J, Prasetyanti, Paramita DK, Prasetyawati AT, Anggrahini DW, Haryana SM, Middeldorp JM
Native Early Antigen of Epstein–Barr Virus, a Promising Antigen for Diagnosis of Nasopharyngeal Carcinoma.
 2007 J Med Virol 79: 1710-21 Paramita DK, Fachiroh J, Artama WT, van Benthem E, Haryana SM, Middeldorp JM
Noninvasive diagnosis of nasopharyngeal
 2006   Stevens SJC,  Verkuijlen SAWM, Hariwiyanto B, Harijadi, Paramita DK, Fachiroh J, Adham M, Tan IB,  Haryana SM,  Middeldorp JM
Single-assay combination of Epstein-Barr Virus (EBV) EBNA1- and viral capsid antigen-p18-derived synthetic peptides for measuring anti-EBV immunoglobulin G (IgG) and IgA antibody levels in sera from nasopharyngeal carcinoma patients: options for field screening.
 2006 J Clin Microbiol 44(4): 1459-67. Fachiroh J, Paramita DK, Hariwiyanto B, Harijadi A, Dahlia HL, Indrasari SR, Kusumo Zeng HYS, Schouten T, Mubarika S, Middeldorp JM
Diagnostic value of measuring Epstein-Barr virus (EBV) DNA load and carcinoma-specific viral mRNA in relation to anti-EBV immunoglobulin A (IgA) and IgG antibody levels in blood of nasopharyngeal carcinoma patients from Indonesia."
 2005 J Clin Microbiol 43(7): 3066-73. Stevens SJC, Verkuijlen SAWM, Hariwiyanto B, Harijadi, Fachiroh J, Paramita DK,T an IB, Haryana SM,  Middeldorp JM
Molecular diversity of Epstein-Barr virus IgG and IgA antibody responses in nasopharyngeal carcinoma: a comparison of Indonesian, Chinese, and European subjects. J Infect Dis 190(1): 53-62.
 2004   Fachiroh J, Schouten T, Hariwiyanto B, Paramita DK,  Harijadi A, Haryana SM, Ng MH,  Middeldorp JM
"Expression of Choline Dehydrogenase in Yeast"
  Journal of Indonesia Biotechnology Yowono T, Fachiroh J, Soedarsono
Kembali